p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p
Abstract The inflammasome sensor NLRP1 is mainly expressed by epithelial cells including keratinocytes of human skin. Germline gain-of-function mutations in NLRP1 cause inflammatory skin syndromes and predispose patients to the development of cutaneous squamous cell carcinomas (cSCCs), a major type...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07785-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849238344931737600 |
|---|---|
| author | Paulina Hennig Patrick Turko Michela Di Filippo Mitchell P. Levesque Thomas Kündig Hans-Dietmar Beer |
| author_facet | Paulina Hennig Patrick Turko Michela Di Filippo Mitchell P. Levesque Thomas Kündig Hans-Dietmar Beer |
| author_sort | Paulina Hennig |
| collection | DOAJ |
| description | Abstract The inflammasome sensor NLRP1 is mainly expressed by epithelial cells including keratinocytes of human skin. Germline gain-of-function mutations in NLRP1 cause inflammatory skin syndromes and predispose patients to the development of cutaneous squamous cell carcinomas (cSCCs), a major type of skin cancer originating from keratinocytes. However, expression of NLRP1 is strongly reduced in cSCCs suggesting a complex role of the NLRP1 inflammasome in the development of this type of skin cancer. Suppression of NLRP1 expression in SCC cells is partially caused by an increase in p62 (SQSTM1), a cargo receptor for autophagy-dependent protein degradation. p62 is upregulated in numerous types of cancer and plays key roles in tumor development by activating different pathways. Here, we characterized the molecular mechanisms underlying suppression of NLRP1 expression by p62 in cSCCs. In SCC cells, NLRP1 activation is rescued by a knockdown or knockout of p62 mRNA and, consequently, protein expression, rather than by a knockout of p62 protein expression only. As these experiments suggest a regulation of NLRP1 by the p62 mRNA, we characterized p62 mRNA-regulated gene expression in SCC cells through RNA sequencing. In addition to mRNAs, we identified several differentially regulated microRNAs (miRs), including miR-34a-5p. These short non-coding RNAs regulate the stability or translation of mRNAs in a dynamic manner and a single miR can target multiple mRNAs. miR-34a-5p is an established tumor suppressor in different types of cancer and its expression is also downregulated in cSCCs. Although miR-34a-5p seems to bind neither p62 nor NLRP1 mRNA directly, it increases NLRP1 expression, most likely through an indirect and complex mechanism, which occurs at the RNA level. In summary, our findings revealed a novel pathway regulating suppression of the inflammasome sensor NLRP1 in SCC cells by p62, which occurs at the mRNA level and is mediated by miRs, including the tumor suppressive miR-34a-5p. Therefore, a pharmacological increase in miR-34a expression represents a treatment option for cSCC patients that allows not only to target know proteins regulated by miR-34a but also a reconstitution of NLRP1 expression. |
| format | Article |
| id | doaj-art-f85f267ce02d4dbbbf11c9b86b7ddd2f |
| institution | Kabale University |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-f85f267ce02d4dbbbf11c9b86b7ddd2f2025-08-20T04:01:40ZengNature Publishing GroupCell Death and Disease2041-48892025-07-0116111010.1038/s41419-025-07785-9p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5pPaulina Hennig0Patrick Turko1Michela Di Filippo2Mitchell P. Levesque3Thomas Kündig4Hans-Dietmar Beer5Department of Dermatology, University Hospital ZurichDepartment of Dermatology, University Hospital ZurichDepartment of Dermatology, University Hospital ZurichDepartment of Dermatology, University Hospital ZurichDepartment of Dermatology, University Hospital ZurichDepartment of Dermatology, University Hospital ZurichAbstract The inflammasome sensor NLRP1 is mainly expressed by epithelial cells including keratinocytes of human skin. Germline gain-of-function mutations in NLRP1 cause inflammatory skin syndromes and predispose patients to the development of cutaneous squamous cell carcinomas (cSCCs), a major type of skin cancer originating from keratinocytes. However, expression of NLRP1 is strongly reduced in cSCCs suggesting a complex role of the NLRP1 inflammasome in the development of this type of skin cancer. Suppression of NLRP1 expression in SCC cells is partially caused by an increase in p62 (SQSTM1), a cargo receptor for autophagy-dependent protein degradation. p62 is upregulated in numerous types of cancer and plays key roles in tumor development by activating different pathways. Here, we characterized the molecular mechanisms underlying suppression of NLRP1 expression by p62 in cSCCs. In SCC cells, NLRP1 activation is rescued by a knockdown or knockout of p62 mRNA and, consequently, protein expression, rather than by a knockout of p62 protein expression only. As these experiments suggest a regulation of NLRP1 by the p62 mRNA, we characterized p62 mRNA-regulated gene expression in SCC cells through RNA sequencing. In addition to mRNAs, we identified several differentially regulated microRNAs (miRs), including miR-34a-5p. These short non-coding RNAs regulate the stability or translation of mRNAs in a dynamic manner and a single miR can target multiple mRNAs. miR-34a-5p is an established tumor suppressor in different types of cancer and its expression is also downregulated in cSCCs. Although miR-34a-5p seems to bind neither p62 nor NLRP1 mRNA directly, it increases NLRP1 expression, most likely through an indirect and complex mechanism, which occurs at the RNA level. In summary, our findings revealed a novel pathway regulating suppression of the inflammasome sensor NLRP1 in SCC cells by p62, which occurs at the mRNA level and is mediated by miRs, including the tumor suppressive miR-34a-5p. Therefore, a pharmacological increase in miR-34a expression represents a treatment option for cSCC patients that allows not only to target know proteins regulated by miR-34a but also a reconstitution of NLRP1 expression.https://doi.org/10.1038/s41419-025-07785-9 |
| spellingShingle | Paulina Hennig Patrick Turko Michela Di Filippo Mitchell P. Levesque Thomas Kündig Hans-Dietmar Beer p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p Cell Death and Disease |
| title | p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p |
| title_full | p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p |
| title_fullStr | p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p |
| title_full_unstemmed | p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p |
| title_short | p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p |
| title_sort | p62 mrna suppresses nlrp1 expression in cutaneous scc cells through mir 34a 5p |
| url | https://doi.org/10.1038/s41419-025-07785-9 |
| work_keys_str_mv | AT paulinahennig p62mrnasuppressesnlrp1expressionincutaneousscccellsthroughmir34a5p AT patrickturko p62mrnasuppressesnlrp1expressionincutaneousscccellsthroughmir34a5p AT micheladifilippo p62mrnasuppressesnlrp1expressionincutaneousscccellsthroughmir34a5p AT mitchellplevesque p62mrnasuppressesnlrp1expressionincutaneousscccellsthroughmir34a5p AT thomaskundig p62mrnasuppressesnlrp1expressionincutaneousscccellsthroughmir34a5p AT hansdietmarbeer p62mrnasuppressesnlrp1expressionincutaneousscccellsthroughmir34a5p |